Trials / Conditions / Portal Vein Tumor Thrombus

Portal Vein Tumor Thrombus

13 registered clinical trials studyying Portal Vein Tumor Thrombus — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Por NCT07483359	First Hospital of China Medical University	Phase 2
Recruiting	BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligomet NCT07062055	Shandong Cancer Hospital and Institute	Phase 2
Recruiting	TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT NCT06622031	Sun Yat-sen University	N/A
Unknown	Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepa NCT06040177	First Affiliated Hospital of Guangxi Medical University	Phase 1 / Phase 2
Completed	HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT NCT04618367	Sun Yat-sen University	N/A
Unknown	Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thro NCT04319484	RenJi Hospital	Phase 2 / Phase 3
Unknown	Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus NCT04069949	Sichuan University	Phase 1 / Phase 2
Unknown	Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT NCT04127396	Beijing Ditan Hospital	Phase 4
Unknown	Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus NCT02971345	Shanghai Zhongshan Hospital	Phase 3
Unknown	A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis NCT03178656	Huazhong University of Science and Technology	Phase 4
Completed	Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus NCT02724475	Eastern Hepatobiliary Surgery Hospital	N/A
Completed	Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion NCT01850368	Korea Cancer Center Hospital	Phase 2
Completed	Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma P NCT00849264	Eastern Hepatobiliary Surgery Hospital	Phase 2